References
- Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57
- Clouse JC, Osterhaus JT. Health care resource use and costs associated with migraine in a managed health care setting. Ann Pharmacother 1984;28:659-64
- Hawkins K, Rupnow MFT, Wang S. Direct cost burden of migraine among members of US employers. Poster presentation at 48th Annual Meeting of the American Headache Society, Los Angeles, CA, June 22-25, 2006.
- Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000;55:754-63
- Brown JS, Papadopoulos G, Neumann PJ, et al. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Headache 2005;45:1012-22
- Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache 2003;43:171-8
- Silberstein SD, Feliu AL, Rupnow MFT, et al. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost. Headache 2007;47:500-10
- Feliu AL, Rupnow MF, Blount A, et al. Resource use associated with topiramate in migraine prophylaxis.. Am J Health Syst Pharm 2007;64:1483-91
- Topamax Package Insert. Titusville, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc; Revised April 2008.
- Silberstein SD, Neto W, Schmitt J, et al. for the MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Archives of Neurology 2004;61:490-5.
- Lipton RB, Bigal ME, Diamond M, et al. on behalf of the AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007:68:343-9.
- Brandes JL, Saper JR, Diamond M, et al. for the MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004:291:965-73.
- Pizzi L, Gagne JJ, Lofland JH, et al. Effect of topiramate migraine prophylaxis on work-place productivity: results from two U.S. randomized, double-blind, placebo-controlled, multicenter trials. Headache 2006;46:852
- Diamond M, Dahlof C, Papadopoulos G, et al. Topiramate improves health-related quality of life when used to prevent migraine. Headache 2005;45:1023-30